Healthcare resource utilization and costs of outpatient follow-up after liver transplantation in a university hospital in São Paulo, Brazil
cost description study
Keywords:
Health care costs, Costs and cost analysis, Liver transplantation, Liver failure, acute, Ambulatory careAbstract
CONTEXT AND OBJECTIVE: Data on the costs of outpatient follow-up after liver transplantation are scarce in Brazil. The purpose of the present study was to estimate the direct medical costs of the out-patient follow-up after liver transplantation, from the first outpatient visit after transplantation to five years after transplantation. DESIGN AND SETTING: Cost description study conducted in a university hospital in São Paulo, Brazil. METHODS: Cost data were available for 20 adults who underwent liver transplantation due to acute liver failure (ALF) from 2005 to 2009. The data were retrospectively retrieved from medical records and the hospital accounting information system from December 2010 to January 2011. RESULTS: Mean cost per patient/year was R$ 13,569 (US$ 5,824). The first year of follow-up was the most expensive (R$ 32,546 or US$ 13,968), and medication was the main driver of total costs, accounting for 85% of the total costs over the five-year period and 71.9% of the first-year total costs. In the second year after transplantation, the mean total costs were about half of the amount of the first-year costs (R$ 15,165 or US$ 6,509). Medication was the largest contributor to the costs followed by hospitalization, over the five-year period. In the fourth year, the costs of diagnostic tests exceeded the hospitalization costs. CONCLUSION: This analysis provides significant insight into the costs of outpatient follow-up after liver transplantation due to ALF and the participation of each cost component in the Brazilian setting.
Downloads
References
Associação Brasileira de Transplante de Órgãos. Dados pediátricos. Dados numéricos da doação de órgãos e transplantes realizados por estado e instituição no período: Janeiro/Dezembro - 2011. Registro Brasileiro de Transplantes (RBT). 2011;XVII(4). Available from: http://www.abto.org.br/abtov03/Upload/file/RBT/Pediatrico/ Pediatrico_2011.pdf. Accessed in 2013 (Nov 1).
Portela MP, Neri ED, Fonteles MM, et al. O custo do transplante hepático em um hospital universitário do Brasil [The cost of liver transplantation at a university hospital of Brazil]. Rev Assoc Med Bras. 2010;56(3):322-6.
Coelho JC, Wiederkehr JC, Lacerda MA, et al. Custo do transplante hepático no Hospital de Clínicas da Universidade Federal do Paraná [Cost of liver transplantation at the Clinical Hospital of the University of Parana, Brazil]. Rev Assoc Med Bras. 1997;43(1):53-7.
Brasil. Ministério da Saúde. Datasus. SIGTAP. Sistema de Gerenciamento da Tabela de Procedimentos, Medicamentos e OPM do SUS. 2008. Available from: http://sigtap.datasus.gov.br/tabela-unificada/app/ sec/inicio.jsp. Accessed in 2013 (Nov 1).
Lucey MR, Terrault N, Ojo L, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1):3-26.
van der Hilst CS, Ijtsma AJ, Slooff MJ, Tenvergert EM. Cost of liver transplantation: a systematic review and meta-analysis comparing the United States with other OECD countries. Med Care Res Rev. 2009;66(1):3-22.
Lee EK, Cham TM, Tseng PL. Using the pharmacoepidemiology approach to evaluate the first-year posttransplantation ambulatory health care cost from the Longitudinal Health Insurance Database (2001 to 2006) in Taiwan. Transplant Proc. 2010;42(3):957-60.
Rufat P, Fourquet F, Conti F, et al. Costs and outcomes of liver transplantation in adults: a prospective, 1-year, follow-up study. GRETHECO study group. Transplantation. 1999;68(1):76-83.
Germani G, Theocharidou E, Adam R, et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol. 2012;57(2):288-96.
Åberg F, Mäklin S, Räsänen P, et al. Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score. Liver Transpl. 2011;17(11):1333-43.
Barbieri M, Drummond M, Rutten F, et al. What do international pharmacoeconomic guidelines say about economic data transferability? Value Health. 2010;13(8):1028-37.
De Soárez PC, Sartori AM, Santos A, et al. Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil. Cad Saude Publica. 2012;28(2):211-28.
Mogyorosy Z, Smith P. The main methodological issues in costing health care services. A literature review. CHE Research Paper 7. York: University of York. Available from: http://www.york.ac.uk/che/pdf/ rp7.pdf. Accessed in 2013 (Nov 1).
